Parties d'ouvrages collectifs (2)
  1. 1. De Vriese, C., Perret, J., & Delporte, C. (2014). Current and future clinical applications of ghrelin. In Endocrine Diseases (pp. 65-102). IConcept Press Ltd.
  2. 2. De Vriese, C., Perret, J., & Delporte, C. (2009). Ghrelin: a peptide involved in the control of appetite. In Appetite and nutritional assessment (pp. 1-48). New York, USA: Ellsworth S.J. and Schuster R.C.(Nova Science Publishers Inc.).
    3.   Articles dans des revues avec comité de lecture (41)
  3. 1. Danneel, C., Sauvage, C., Hayef, M. N., Desmet, V., Surquin, M., Nortier, J., & De Vriese, C. (2025). Critical Review of the Benefit from Early Pharmacological and Dietary Support for Patients with Moderate-to-Severe (Non-Terminal) Chronic Kidney Disease. Biomedicines, 13(4). doi:10.3390/biomedicines13040994
  4. 2. Biset, N., Rosiere, A., Lartigue, V., Pochet, S., & De Vriese, C. (2024). Patients and healthcare practitioners' perspective on the development of a digital interprofessional intervention for COPD. Digital health, 10, 20552076241288317. doi:10.1177/20552076241288317
  5. 3. Schils, A., Lechon, A.-S., Rondeaux, S., Souard, F., Van Laethem, J.-L., Pochet, S., Mathieu, V., & De Vriese, C. (2023). Cancer patients' behaviors and attitudes toward natural health products. BMC complementary medicine and therapies, 23(1), 442, 1-14. doi:10.1186/s12906-023-04278-0
  6. 4. Macé, F., De Vriese, C., Nelissen-Vrancken, M., Ruggli, M., Brülhart, M., & Peyron, C. (2023). General practitioners-community pharmacists pharmacotherapy discussion groups: Analysis of their implementation through a series of case studies. Exploratory research in clinical and social pharmacy, 12, 100331. doi:10.1016/j.rcsop.2023.100331
  7. 5. Biset, N., Lelubre, M., Pochet, S., & De Vriese, C. (2023). Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium. Pharmaceuticals, 16(7). doi:10.3390/ph16071030
  8. 6. Rondeaux, S., Braeckman, T., Beckwé, M., El Oueriaghli El Ghammaz, D., Devroey, D., & De Vriese, C. (2023). Design and Development of Tools for Risk Evaluation of Diabetes and Cardiovascular Disease in Community Pharmacy. International journal of environmental research and public Health, 20(4). doi:10.3390/ijerph20042819
  9. 7. Pochet, S., Lechon, A.-S., Lescrainier, C., De Vriese, C., Mathieu, V., Hamdani, J., & Souard, F. (2022). Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database. Scientific reports, 12(1), 14178. doi:10.1038/s41598-022-17704-z
  10. 8. Rondeaux, S., Braeckman, T., Beckwé, M., Biset, N., Maesschalck, J., Duquet, N., De Wulf, I., Devroey, D., & De Vriese, C. (2022). Diabetes and Cardiovascular Diseases Risk Assessment in Community Pharmacies: An Implementation Study. International journal of environmental research and public Health, 19(14). doi:10.3390/ijerph19148699
  11. 9. Biset, N., Kestens, W., Detemmerman, D., Lona, M., Karakaya, G., Ceuppens, A., Pochet, S., & De Vriese, C. (2022). Analysis of the Consumption of Drugs Prescribed for the Treatment of Asthma in Belgian Children. International Journal of Environmental Research and Public Health, 19(1), 548. doi:10.3390/ijerph19010548
  12. 10. Koubaity, M., Lechon, A.-S., Amighi, K., Van Nuffelen, M., Moreau, M., Meert, A.-P., & De Vriese, C. (2021). Drug-related problems and risk factors related to unplanned hospital readmission among cancer patients in Belgium. Supportive care in cancer. doi:10.1007/s00520-020-05916-w
    13. << Précédent 1 2 3 4 5 6 7 8 9 Suivant >>